Table 4.
Model 1 | Model 2 | |
---|---|---|
Intercept |
25.20 (22.99, 27.41) t = 22.34*** |
22.29 (19.90, 24.68) t = 18.31*** |
Baseline PCL-5 ≥ 31 (Ref: PCL < 31) |
21.76 (19.09, 24.42) t = 16.00*** |
26.82 (23.67, 29.96) t = 16.73*** |
Week |
− 2.53 (− 3.09, − 1.98) t = − 8.95*** |
− 0.81 (− 1.61, − 0.01) t = − 1.99* |
Week2 |
0.06 (0.03, 0.10) t = 3.82*** |
− 0.01 (− 0.06, 0.04) t = − 0.51 |
Week * Baseline PCL-5 ≥ 31 |
− 2.99 (− 4.04, − 1.95) t = − 5.64*** |
|
Week2 * Baseline PCL-5 ≥ 31 |
0.14 (0.07, 0.20) t = 4.11*** |
|
Deviance (− 2*Log likelihood) | 10,443.05 | 10,406.47 |
Akaike inf. crit | 10,465.05 | 10,432.47 |
Bayesian inf. crit | 10,523.04 | 10,501.01 |
PCL-5: PTSD Checklist for DSM-5. Baseline PCL-5 indicator is coded: 0 = PCL-5 < 31, 1 = PCL-5 ≥ 31. Model 1 residual degrees of freedom = 1428, and Model 2 residual degrees of freedom = 1426. Likelihood ratio test: (2) = 36.57, p < 0.001.
*p < 0.05; **p < 0.01; ***p < 0.001.